Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0400
0.00 (0.00%)
Jul 28, 2025, 2:03 PM AEST
Resonance Health Market Cap
Resonance Health has a market cap or net worth of 18.38 million as of July 28, 2025. Its market cap has decreased by -45.15% in one year.
Market Cap
18.38M
Enterprise Value
18.47M
Revenue
10.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 25, 1994, Resonance Health's market cap has increased from 1.44M to 18.38M, an increase of 1,173.99%. That is a compound annual growth rate of 8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 18.38M | -23.08% |
| Dec 30, 2024 | 23.90M | -14.68% |
| Dec 29, 2023 | 28.01M | 1.25% |
| Dec 30, 2022 | 27.67M | -57.14% |
| Dec 31, 2021 | 64.56M | -39.91% |
| Dec 31, 2020 | 107.45M | 11.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.02B |
| Pro Medicus | 33.47B |
| Cochlear | 20.73B |
| Sonic Healthcare | 13.95B |
| Ramsay Health Care | 8.93B |
| Telix Pharmaceuticals | 7.14B |
| Ansell | 4.47B |
| Mesoblast | 3.19B |